Transcriptional control of CNS myelination in development and maturity.
In plain English
AI plain-English summaryThe brain continues to manufacture new myelin—the fatty insulation around nerve fibres—well into adulthood, and this project aims to discover the genetic switches that control that process. Most myelin-making cells, called oligodendrocytes, form shortly after birth, but fresh ones keep appearing throughout healthy adult life, possibly helping with learning and memory. These cells arise from precursor cells that can also turn into other brain cell types. Understanding the genetic mechanisms that govern this production line could open routes to treatments for demyelinating diseases such as multiple sclerosis, where the loss of myelin disrupts nerve signalling. The researchers will focus on a family of proteins called Olig transcription factors, which act as master regulators of oligodendrocyte development. They will use genetically modified mice to watch new myelin being made in real time, and will map how chemical modifications to Olig proteins alter their behaviour and target genes. They will also identify the signalling pathways that trigger these modifications. This is fundamental science. If successful, it will provide a detailed molecular blueprint for generating oligodendrocytes from stem cells in the lab—a step toward cell-replacement therapies for demyelinating disease. Similar fundamental work on transcription factors has already enabled the direct reprogramming of skin cells into neurons.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know